Open Label Vancomycin in Primary Sclerosing Cholangitis-Inflammatory Bowel Disease: Improved Colonic Disease Activity and Associations With Changes in Host-Microbiome-Metabolomic Signatures. - Quraishi MN; Cheesbrough J; Rimmer P; Mullish BH; Sharma N; Efstathiou E; Acharjee A; Gkoutus G; Patel A; Marchesi JR; Camuzeaux S; Chappell K; et al. (Journal of Crohn's & colitis, 2025)